Загрузка...
Emerging Treatments in Recurrent and Metastatic Colorectal Cancer
Metastatic colorectal cancer (mCRC) is a prevalent disease for which many new therapies have been developed over the past decade. Currently, standard of care chemotherapeutic regimens for mCRC include doublet cytotoxic chemotherapy with or without the anti–vascular endothelial growth factor (VEGF) m...
Сохранить в:
| Опубликовано в: : | J Natl Compr Canc Netw |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6645683/ https://ncbi.nlm.nih.gov/pubmed/24158967 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|